These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34783037)

  • 61. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma1.
    Yi P; Han Z; Li X; Olson EN
    Science; 2006 Sep; 313(5791):1301-3. PubMed ID: 16857902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation.
    Xu N; Shen N; Wang X; Jiang S; Xue B; Li C
    Sci China Life Sci; 2015 Apr; 58(4):328-35. PubMed ID: 25862656
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.
    Karbowniczek M; Cash T; Cheung M; Robertson GP; Astrinidis A; Henske EP
    J Biol Chem; 2004 Jul; 279(29):29930-7. PubMed ID: 15150271
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.
    Dricu A; Wang M; Hjertman M; Malec M; Blegen H; Wejde J; Carlberg M; Larsson O
    Glycobiology; 1997 Jul; 7(5):625-33. PubMed ID: 9254045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
    Todenhöfer T; Hennenlotter J; Kühs U; Gerber V; Gakis G; Vogel U; Aufderklamm S; Merseburger A; Knapp J; Stenzl A; Schwentner C
    World J Urol; 2013 Apr; 31(2):345-50. PubMed ID: 22407328
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins.
    Yu R; Longo J; van Leeuwen JE; Mullen PJ; Ba-Alawi W; Haibe-Kains B; Penn LZ
    Cancer Res; 2018 Mar; 78(5):1347-1357. PubMed ID: 29229608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation.
    Laezza C; Notarnicola M; Caruso MG; Messa C; Macchia M; Bertini S; Minutolo F; Portella G; Fiorentino L; Stingo S; Bifulco M
    FASEB J; 2006 Mar; 20(3):412-8. PubMed ID: 16507758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. How prenylation and S-acylation regulate subcellular targeting and function of ROP GTPases.
    Sorek N; Henis YI; Yalovsky S
    Plant Signal Behav; 2011 Jul; 6(7):1026-9. PubMed ID: 21694496
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
    Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
    Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Statins Perturb G
    Tennakoon M; Kankanamge D; Senarath K; Fasih Z; Karunarathne A
    Mol Pharmacol; 2019 Apr; 95(4):361-375. PubMed ID: 30765461
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.
    Das S; Edwards PA; Crockett JC; Rogers MJ
    Biochim Biophys Acta; 2014 Apr; 1841(4):569-73. PubMed ID: 24369118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
    Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
    Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.
    Ding H; McDonald JS; Yun S; Schneider PA; Peterson KL; Flatten KS; Loegering DA; Oberg AL; Riska SM; Huang S; Sinicrope FA; Adjei AA; Karp JE; Meng XW; Kaufmann SH
    Haematologica; 2014 Jan; 99(1):60-9. PubMed ID: 23996484
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells.
    Zheng H; Liu A; Liu B; Li M; Yu H; Luo X
    Cancer Lett; 2010 Nov; 297(1):117-25. PubMed ID: 20554106
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of Mevalonate Pathway Prevents Adipocyte Browning in Mice and Men by Affecting Protein Prenylation.
    Balaz M; Becker AS; Balazova L; Straub L; Müller J; Gashi G; Maushart CI; Sun W; Dong H; Moser C; Horvath C; Efthymiou V; Rachamin Y; Modica S; Zellweger C; Bacanovic S; Stefanicka P; Varga L; Ukropcova B; Profant M; Opitz L; Amri EZ; Akula MK; Bergo M; Ukropec J; Falk C; Zamboni N; Betz MJ; Burger IA; Wolfrum C
    Cell Metab; 2019 Apr; 29(4):901-916.e8. PubMed ID: 30581121
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
    Politiek FA; Waterham HR
    Front Immunol; 2021; 12():724991. PubMed ID: 34539662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment.
    Angarola B; Ferguson SM
    Mol Biol Cell; 2019 Oct; 30(22):2750-2760. PubMed ID: 31532697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting the Mevalonate Pathway in Cancer.
    Juarez D; Fruman DA
    Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.